Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.
Priscilla Zawislak
Advertisement
Priscilla Zawislak is global regulatory affairs advocacy manager, DuPont Nutrition & Biosciences
Articles by Priscilla Zawislak
With ingredients sold to multiple markets, excipient manufacturers must understand the different regulatory requirements for pharma vs. food.
This article seeks to encourage continued dialogue among stakeholders to achieve consensus regarding excipient additives and processing aids.
Increasingly stringent audit requirements will make third-party accredited GMP audits critical for pharmaceutical excipients and raw materials.
This article seeks to promote dialogue among stakeholders to facilitate consensus regarding requirements for excipients.
Advertisement
Latest Updated Articles
Understanding Concomitant Components in Pharmaceutical ExcipientsPublished: February 3rd 2021 | Updated:
The Real Complexity of Excipient CompositionPublished: October 2nd 2017 | Updated:
Third-Party Audits: Ensuring That Excipients Meet cGMP RequirementsPublished: September 1st 2018 | Updated:
Additives and Processing Aids in Pharmaceutical ExcipientsPublished: October 1st 2019 | Updated:
Comparison of Pharmaceutical Excipients and Food Ingredient RequirementsPublished: April 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Challenges for the Global Manufacturing of Vaccines
5
